tradingkey.logo

Bristol Myers Squibb And Bain Capital Create New Company Dedicated To Developing Innovative Immunology Therapies That Address The Unmet Medical Needs Of Patients

ReutersJul 28, 2025 9:07 PM

Bristol-Myers Squibb Co BMY.N:

  • BRISTOL MYERS SQUIBB AND BAIN CAPITAL CREATE NEW COMPANY DEDICATED TO DEVELOPING INNOVATIVE IMMUNOLOGY THERAPIES THAT ADDRESS THE UNMET MEDICAL NEEDS OF PATIENTS

  • BRISTOL-MYERS SQUIBB CO - BAIN CAPITAL LEADS $300 MILLION FINANCING COMMITMENT

  • BRISTOL-MYERS SQUIBB CO - BMS RETAINS NEARLY 20% EQUITY STAKE IN NEWCO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI